MedPath
HSA Approval

PANTOTAB GASTRO RESISTANT TABLETS 40 MG

SIN15863P

PANTOTAB GASTRO RESISTANT TABLETS 40 MG

PANTOTAB GASTRO RESISTANT TABLETS 40 MG

December 2, 2019

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

A02BC02

pantoprazole

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

MICRO LABS LIMITED

Active Ingredients

Pantoprazole Sodium Sesquihydrate 45.112mg eqv Pantoprazole

40 mg

Pantoprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PANTOTAB GASTRO RESISTANT TABLETS 40 MG - HSA Approval | MedPath